We read with interest the article by Lockington et al1 on tissue reaction to gold eyelid weights; herein we describe, to the best of our knowledge, the first reported case of symptomatic tissue reaction to a platinum eyelid weight.
An 85-year-old man underwent pretarsal insertion of an upper-eyelid, 1.2-g, platinum-iridium eyelid chain (Spiggle & Theis GmbH, Dieburg, Germany) for exposure keratopathy due to nonresolving Bell palsy. He presented 5 months later with good recovery of orbicularis function but had upper-eyelid pretarsal edema and erythema; there was no significant pain or tenderness. The chain was explanted at 6 months. Intraoperatively, there was fibrosis around the chain and within fixation holes. There were fine black particles seen in tissue adjacent to the chain. The chain appeared well fixated to the tarsus, with no mobility. The pretarsal edema resolved following explantation, and the patient remained free of complications at follow-up 2 months later.
Figure 1. Mild lymphocytic inflammatory infiltrate associated with dense focally diathermied collagen with deposition of black granules, free-lying and in the cytoplasm of histiocytes and a multinucleate giant cell (arrow) (hematoxylin-eosin; original magnification ×400).
Figure 2. Trace from energy dispersive X-ray spectrometry showing peak for platinum (Pt).
Thank you for submitting a comment on this article. It will be reviewed by JAMA Ophthalmology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.